D.E. Shaw & Co
MDT icon

D.E. Shaw & Co’s Medtronic MDT Stock Holding History

D.E. Shaw & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.51M Sell
63,600
-77,600
-55% -$7.43M ﹤0.01% 2100
2025
Q4 		$13.6M Sell
141,200
-129,700
-48% -$12.6M 0.01% 1502
2025
Q3 		$25.8M Buy
270,900
+156,800
+137% +$14.4M 0.01% 1010
2025
Q2 		$9.95M Buy
+114,100
New +$9.68M 0.01% 1495
2024
Q4 		– Sell
-43,100
Closed -$3.88M – 4672
2024
Q3 		$3.88M Sell
43,100
-46,900
-52% -$3.95M ﹤0.01% 2150
2024
Q2 		$7.08M Sell
90,000
-59,800
-40% -$4.9M 0.01% 1591
2024
Q1 		$13.1M Sell
149,800
-200
-0.1% -$17.1K 0.01% 1194
2023
Q4 		$12.4M Buy
150,000
+40,000
+36% +$3.05M 0.01% 1223
2023
Q3 		$8.62M Buy
+110,000
New +$9.21M 0.01% 1391
2023
Q1 		– Sell
-29,100
Closed -$2.26M – 4694
2022
Q4 		$2.26M Buy
+29,100
New +$2.36M ﹤0.01% 2838
2022
Q3 		– Sell
-125,400
Closed -$11.3M – 5382
2022
Q2 		$11.3M Buy
125,400
+25,400
+25% +$2.57M 0.01% 1290
2022
Q1 		$11.1M Sell
100,000
-140,400
-58% -$14.8M 0.01% 1508
2021
Q4 		$24.9M Buy
+240,400
New +$27.8M 0.02% 937
2021
Q3 		– Sell
-71,900
Closed -$8.93M – 5110
2021
Q2 		$8.93M Buy
+71,900
New +$9.03M 0.01% 1583
2021
Q1 		– Sell
-68,800
Closed -$8.06M – 4310
2020
Q4 		$8.06M Buy
68,800
+18,700
+37% +$2.06M 0.01% 1510
2020
Q3 		$5.21M Sell
50,100
-3,900
-7% -$392K 0.01% 1653
2020
Q2 		$4.95M Sell
54,000
-9,800
-15% -$940K 0.01% 1668
2020
Q1 		$5.75M Sell
63,800
-93,800
-60% -$9.98M 0.01% 1369
2019
Q4 		$17.9M Buy
157,600
+35,000
+29% +$3.84M 0.02% 872
2019
Q3 		$13.3M Buy
+122,600
New +$12.8M 0.02% 989
2019
Q2 		– Sell
-169,000
Closed -$15.4M – 3775
2019
Q1 		$15.4M Buy
+169,000
New +$15.1M 0.02% 858
2018
Q3 		– Sell
-30,200
Closed -$2.58M – 3868
2018
Q2 		$2.58M Buy
+30,200
New +$2.52M ﹤0.01% 2035
2018
Q1 		– Sell
-48,300
Closed -$3.9M – 3657
2017
Q4 		$3.9M Sell
48,300
-600
-1% -$48.1K 0.01% 1656
2017
Q3 		$3.8M Sell
48,900
-90,200
-65% -$7.49M 0.01% 1580
2017
Q2 		$12.3M Buy
139,100
+25,300
+22% +$2.13M 0.02% 793
2017
Q1 		$9.17M Buy
113,800
+13,800
+14% +$1.08M 0.02% 934
2016
Q4 		$7.12M Sell
100,000
-115,100
-54% -$9.04M 0.01% 1143
2016
Q3 		$18.6M Buy
215,100
+126,500
+143% +$11M 0.03% 606
2016
Q2 		$7.69M Buy
+88,600
New +$7.16M 0.01% 1041
2016
Q1 		– Sell
-328,300
Closed -$25.3M – 3635
2015
Q4 		$25.3M Buy
328,300
+142,100
+76% +$10.7M 0.04% 543
2015
Q3 		$12.5M Buy
186,200
+36,700
+25% +$2.7M 0.02% 840
2015
Q2 		$11.1M Sell
149,500
-20,600
-12% -$1.57M 0.02% 965
2015
Q1 		$13.3M Sell
170,100
-6,700
-4% -$508K 0.02% 815
2014
Q4 		$12.8M Sell
176,800
-119,800
-40% -$8.32M 0.02% 950
2014
Q3 		$18.4M Sell
296,600
-12,100
-4% -$769K 0.02% 743
2014
Q2 		$19.7M Buy
308,700
+41,500
+16% +$2.52M 0.03% 699
2014
Q1 		$16.4M Hold
267,200
– – 0.02% 760
2013
Q4 		$15.3M Sell
267,200
-600
-0.2% -$34K 0.02% 844
2013
Q3 		$14.3M Buy
267,800
+135,700
+103% +$7.3M 0.02% 770
2013
Q2 		$6.8M Buy
+132,100
New +$6.53M 0.01% 1139

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co's MDT Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Medtronic (MDT) stake by 9.8% in Q1 2026, selling an estimated $9.29M and leaving 894,615 shares worth $77.5M. The position accounts for 0.05% of the portfolio, ranked #476.

D.E. Shaw & Co first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. The position peaked at $519M in Q2 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • D.E. Shaw & Co held 894,615 shares of Medtronic worth $77.5M as of Q1 2026.
  • D.E. Shaw & Co sold 96,999 Medtronic shares in Q1 2026, an estimated $9.29M.
  • Medtronic made up 0.05% of D.E. Shaw & Co's portfolio in Q1 2026, its #476 holding.
  • D.E. Shaw & Co first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
  • D.E. Shaw & Co's Medtronic position peaked at $519M in Q2 2019.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.